Changchun Wancheng Bio-Electron Recalls Male Fertility Sperm Tests Due to Lack of FDA Clearance
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Changchun Wancheng Bio-Electron Co., Ltd. is recalling 1,000 home sperm test kits distributed in the U.S. because the devices were marketed without required regulatory approval.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevice.
What Happened
Changchun Wancheng Bio-Electron Co., Ltd. has initiated a voluntary recall of its Male Fertility Sperm Test for Home Use (Cassette). The recall was prompted because the test strips and diagnostic components were distributed to U.S. customers before they could be legally marketed through the required 510(k) clearance process. According to the FDA, these unapproved devices may produce false or inaccurate diagnostic results, which could lead consumers to pursue inappropriate medical interventions.
Which Products Are Affected
The recall involves approximately 1,000 units of the following product:
- Product Name: Male Fertility Sperm Test for Home Use (Cassette)
- Lot Number: GT-SPA 20251601
- Expiration Date: 05-2027
- Recall Number: Z-1262-2026
The affected products were distributed nationwide within the United States, with confirmed distribution in Texas, Georgia, and California.
What You Should Do
Consumers who have purchased the affected test kits should stop using them immediately. The recalling firm, Changchun Wancheng Bio-Electron Co., Ltd., initiated the notification process via letter. Consumers seeking information regarding returns or refunds should contact the firm at their headquarters at 2336, Tianwei Road, Beihu Science and Technology Development Zone, Changchun, China.
Why This Matters
The use of diagnostic tests that have not been cleared by the FDA poses a risk of inaccurate health data. Inaccurate results from a fertility test could lead to incorrect self-diagnosis and unnecessary or harmful medical decisions.
Source
Information provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.